UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Explore the best credit cards with outstanding rewards structures. Maximize your benefits and make the most of your spending.
27,354 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
SpaceX has landed a historic IPO. This article lays out a 180-day plan for investors, with key dates, valuations, and...
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
As Costco shares hover near $970, analysts outline a constructive path to $1,000 and beyond, driven by membership mom...
Tesla sits near the $400 mark as investors weigh future growth against current prices. This guide helps you decide wh...
Rigetti Computing stock just took a sharp turn lower, surprising many investors who had hoped for a steady rise in a ...
Playnance launches the G Coin presale on March 18, positioning the token as the utility layer for an ecosystem with h...
North Dakota is quietly attracting retirees thanks to affordability, space, and simpler living, even as cold winters ...
AI is reshaping the data center landscape, and Marvell is at the center of the action. This piece breaks down why mar...
A rising Medicare surcharge tied to two-year look-back income means some inheritors face unexpectedly higher bills. T...
A veteran Wall Street observer reveals a clean, repeatable way to find the next big chip stock winners. Read how to s...
OpenUSD, backed by Visa, Mastercard and more, challenges Circle's stablecoin dominance. Analysts debate whether Circl...